Published: 2 March 2017

Publications

Tramadol in Children

This article is more than five years old. Some content may no longer be current.

Prescriber Update 38(1): 4
March 2017

The use of tramadol in children was discussed by the Medicines Adverse Reactions Committee (MARC) in 2016 (www.medsafe.govt.nz/profs/adverse/Minutes166.htm#3.2.3).

Tramadol is indicated for the relief of moderate to severe pain in adults and children. Most of the studies conducted in children investigated the use of tramadol in postoperative pain. The MARC considered that there is a role for the use of tramadol in children. However, as there is very limited data on the efficacy and safety in younger children, the MARC recommended that tramadol should be contraindicated in children aged two years and under. The tramadol data sheets are in the process of being updated with this contraindication as well as additional information on use following tonsillectomy, adenoidectomy or throat surgery.

Further information on the use of tramadol is available at www.medsafe.govt.nz/profs/PUArticles/December2014Tramadol.htm.

Recent Funding Change

PHARMAC has released its decision on the funding of tramadol oral drops in Section H of the Pharmaceutical Schedule (hospital pharmaceuticals). The decision is to:

• list tramadol oral drops 10 mg/mL from 1 January 2017
• delist tramadol oral drops 100 mg/mL from 30 June 2017.

Please take care when prescribing, dispensing and administering tramadol oral drops during this transition period to ensure the correct dose is given to the patient.

Further information on this change in funding is available on the PHARMAC website (www.pharmac.govt.nz/news/notification-2016-12-13-tramadol-hydrochloride/).